Skip to Content

Unigene Laboratories Inc - Stock Quote UGNEQ

Rating as of

Morningstar's Unigene Laboratories Inc Stock Analysis

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - UGNEQ

Unigene Laboratories Inc's Company Profile

Business Description

Unigene Laboratories Inc is engaged in the research, production, and drug delivery of peptides for therapeutic use in the United States.

81 Fulton Street
Boonton, NJ, 07005
T +1 973 265-1100
Industry Biotechnology
Most Recent Earnings Mar 31, 2013
Fiscal Year End Dec 31, 2013
Stock Type Distressed
Employees 53